BCL2L1 and neuroblastoma: Since we and others [21, 22] have recently shown that BH3-mimetics and in particular inhibitors of MCL1 or BCL-XL may increase the cytotoxicity of NK cells, we asked whether NK cells may be able to combat chemoresistance in neuroblastoma.